Nu Skin Enterprises (NUS) Reports In-Line Q1 EPS, Revenues Beat; Affirms FY19 EPS/Revenue Mid-Point Guidance Above Consensus, Provides 2Q EPS/Revenue Outlook
Nu Skin Enterprises (NYSE: NUS) reported Q1 EPS of $0.71, in-line with the analyst estimate of $0.71. Revenue for the quarter came in at $623.6 million versus the consensus estimate of $615.84 million.
"We are encouraged by the positive start to the year, which began with a strong first quarter highlighted by 7 percent local-currency growth," said Ritch Wood, chief executive officer. "We were particularly pleased with local-currency revenue growth in nearly all our reporting segments, highlighted by 12 percent growth in Mainland China and 5 percent growth in Southeast Asia, or 6 percent and 2 percent on a reported basis, respectively. We continue to focus our global efforts on expanding our customer base through our Nu Skin growth strategy, which helped to drive a 10 percent increase in customers during the quarter."
"We remain confident in our growth prospects in 2019 as we focus on the continued execution of our growth strategy," said Wood. "We will drive increased productivity by investing in technologies to better support our sales leaders, expanding our global beauty device systems with product introductions and line extensions, and optimizing our Velocity sales compensation program."
"Our solid first quarter results keep us on track to achieve a strong year," said Mark Lawrence, chief financial officer. "Our 2019 annual revenue guidance is $2.76 to $2.81 billion with an approximate 2 to 3 percent unfavorable foreign currency impact, and earnings per share of $3.80 to $4.05. For the second quarter, we project revenue of $660 to $680 million with an approximate 4 to 5 percent negative foreign currency impact. The prior-year period included a strong LumiSpa introduction in Mainland China while current year product launches are slated for the back half of the year. We project earnings per share of $0.91 to $0.98."
GUIDANCE:
Nu Skin Enterprises sees Q2 2019 EPS of $0.91-$0.98, versus the consensus of $0.96. Nu Skin Enterprises sees Q2 2019 revenue of $660-680 million, versus the consensus of $705.08 million.
Nu Skin Enterprises sees FY2019 EPS of $3.80-$4.05, versus the consensus of $3.88. Nu Skin Enterprises sees FY2019 revenue of $2.76-2.81 billion, versus the consensus of $2.76 billion.
For earnings history and earnings-related data on Nu Skin Enterprises (NUS) click here.
